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Trichloroethylene (TCE) is known as a major
pollutant that affects both the occupational
and general environment. It has been used as
an industrial degreasing agent, solvent, and
extraction agent for approximately a century.
Alternatively, the general population may be
exposed to TCE through contaminated drink-
ing water or air. The target organs of TCE
include the nervous system, 1iver, kidney,
heart, and skin (Bruckner et al. 1989). Among
the immunotoxicity end points, evidence for
an effect of TCE was strongest for auto-
immune disease. Studies in susceptible rodents
have shown that TCE exacerbates underlying
autoimmune disease, and supporting informa-
tion comes from multiple human studies of
scleroderma and exposure to organic solvents
(National Research Council 2006).
Hypersensitivity dermatitis occurring in
workers exposed to TCE is completely differ-
ent from nonspeciﬁc skin irritation as a result
of defatting action, and the serious conse-
quences of TCE exposure have recently
become one of the critical occupational health
issues in Asia. The clinical manifestations of
TCE exposure include generalized severe
dermatitis, fever, abnormal liver function,
jaundice, and lymphadenopathy. Skin lesions
range from mild multiform erythema to
lesions with increasing severity, exfoliative der-
matitis, Stevens-Johnson syndrome, and toxic
epidermal necrolysis (Huang et al. 2006). The
literature published in English and ad hoc
publications in local languages were reviewed
in detail recently by Kamijima et al. (2007).
Occurrences of the disease have been reported
from the United States, Japan, Spain,
Singapore, China, Korea, Thailand, and the
Philippines. Most case reports from industrial-
ized countries were published up to 1990,
whereas cases from Asian industrializing coun-
tries were published later. In the past 10 years,
an increasing number of cases of hypersensitiv-
ity dermatitis have been reported among TCE-
exposed workers from electronic-element plants
in Guangdong Province in southern China
(Huang et al. 2002; Kamijima et al. 2007).
According to epidemiologic surveys in
Guangdong Province, > 200 cases of hyper-
sensitivity dermatitis have been diagnosed,
with a prevalence rate of < 1% among TCE-
exposed workers (Huang and Li 2006).
Epidemiologic studies on patients with TCE-
induced hypersensitivity dermatitis reveal that
the latency ranges from 6 to 89 days, and a
no dose–response relationship was observed
(Li et al. 2006). Furthermore, the patch test
using TCE and/or its oxidative metabolites
among victims was positive (Huang et al.
2002).
The incidence of hypersensitivity and
autoimmune diseases in industrialized coun-
tries has steadily increased over the past three
decades (Bach 2002), and these diseases are
not evenly distributed among countries,
regions, or ethnic groups. However, the
degree to which genetic and environmental
factors inﬂuence susceptibility to hypersensi-
tivity and autoimmune diseases is not well
defined. One main feature of occupational
diseases is relatively deﬁned causative factors,
so studies on these diseases are helpful in
identifying the role of genetic factors.
One of the best ways to prevent occupa-
tional hypersensitivity disease is to identify
susceptible biomarkers to use in screening
employees before exposure. To date, however,
there are no available biomarkers for predict-
ing who among TCE-exposed workers is at
high risk of developing hypersensitivity der-
matitis. Other factors associated with the dis-
ease remain unknown except for human
herpes virus 6 reactivation (Huang et al.
2006). The genomic region of human leuko-
cyte antigen (HLA) at chromosomal position
6p21 encodes the six classical HLA genes and
many other genes that have important roles in
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BACKGROUND: Trichloroethylene (TCE) is used extensively as an industrial solvent and has been
recognized as one of the major environmental pollutants. To date, > 200 cases of TCE-induced
hypersensitivity dermatitis among exposed workers have been reported worldwide, and TCE expo-
sure has become one of the critical occupational health issues in Asia. 
OBJECTIVES: The study aimed to identify genetic susceptible biomarkers associated with the TCE-
induced hypersensitivity dermatitis in genes located in the human leukocyte antigen (HLA) region.
METHODS: From 1998 to 2006, 121 cases with TCE-induced hypersensitivity dermatitis and 142 tol-
erant controls were recruited into the population-based case–control study. We determined HLA alle-
les B, DRB1, DQA1, and DQB1, by sequence-based typing. p-Values were corrected for comparisons
of multiple HLA alleles. In addition, we compared and analyzed the structure character of amino acid
residues of HLA molecules found in participants. 
RESULTS: We obtained complete genotyping data of 113 cases and 142 controls. The allele
HLA-B*1301 was present in 83 (73.5%) of 113 patients compared with 13 (9.2%) of 142 tolerant
workers (odds ratio = 27.5; 95% conﬁdence interval, 13.5–55.7; corrected p = 1.48 × 10–21). In
addition, the HLA-B*44 alleles were present in 6.2% (7/113) of patients, but were absent in TCE-
tolerant workers. Residue 95 shared by HLA-B*1301 and HLA-B*44 molecules formed a different
pocket F than other residues. 
CONCLUSIONS: The allele HLA-B*1301 is strongly associated with TCE-induced hypersensitivity
dermatitis among exposed workers and might be used as a biomarker to predict high risk individu-
als to TCE.
KEY WORDS: biomarkers, genetic polymorphism, human leukocyte antigen, hypersensitivity dermati-
tis, trichloroethylene. Environ Health Perspect 115:1553–1556 (2007). doi:10.1289/ehp.10325 avail-
able via http://dx.doi.org/ [Online 24 August 2007]the regulation of the immune system as well as
in some fundamental cellular processes. The
classical class I (HLA-A, HLA-B, and HLA-C)
and class II molecules (HLA-DR, HLA-DQ,
and HLA-DP) are involved in the control of
immune-response mediation of antigen presen-
tation to the T lymphocytes, and play a central
role in the immune system by presenting pep-
tides (Shiina et al. 2004). The HLAs are char-
acterized by an extensive degree of allelic
polymorphism; strong associations between
hypersensitivity or autoimmune disease and
certain HLA alleles have been reported, for
instance, HLA-B*27 and ankylosing spondyli-
tis (Brewerton et al. 1973), and HLA-B*1502
and carbamazepine-induced Stevens-Johnson
syndrome (Chung et al. 2004). Therefore, we
hypothesized that the polymorphisms of HLA
loci might inﬂuence the susceptibility of TCE-
induced hypersensitivity dermatitis. We con-
ducted a population-based case–control study
to investigate this hypothesis.
Materials and Methods
Study population. From June 1998 to March
2006, 121 cases with TCE-induced hypersen-
sitivity dermatitis and 142 TCE-tolerant con-
trols were recruited into the case–control
study. Both cases and controls were recruited
from 80 factories engaged in electronic-ele-
ment and metal-plating production in
Guangdong Province, China. At least one
patient was identiﬁed in each factory. Controls
were deﬁned as the co-workers of the patients
with same job title and longer occupational
exposure time (> 90 days) but no skin abnor-
malities detected by the occupational physi-
cians upon examination. According to data of
routine environmental monitoring in the years
the cases occurred, the TCE levels in these
workplaces ranged from 69 to 790 ppm
(median concentration, 90 ppm), which is
much higher than the permissible concentra-
tion time-weighted average of 5.6 ppm deﬁned
by the Ministry of Health, China (2002b).
Compared with the exposure data reviewed by
Kamijima et al. (2007), the environmental
exposure concentrations in the present study
were relatively high. All participants were from
the southern region of China and were geneti-
cally unrelated. Both cases and controls were
exposed to TCE in the workplace where they
cleaned and degreased metals. The cases
were diagnosed with occupational hypersensi-
tivity dermatitis by a panel of occupational
physicians according to Chinese National
Diagnostic Criteria of Occupational Disease
(GBZ38-2002) (2002a). Brieﬂy, on the basis
of both TCE exposure history and clinical
manifestations (in terms of dermatitis accom-
panied by fever, lymphadenopathy, and hepati-
tis), patients were judged to be cases if the
onset of symptoms occurred within the first
3 months of TCE exposure. Other potential
risk factors, such as medications used and the
history of previous skin disease, were excluded
during diagnosis. 
Four clinical categories were defined
among the cases. First, exfoliative dermatitis is
characterized by cutaneous ﬁne pink macules
and multiorgan involvement (e.g., hepatitis,
nephritis) accompanied by systemic manifesta-
tions (e.g., fever, eosinophilia, lymphadenopa-
thy, hepatomegaly, splenomegaly) in addition
to skin rashes. Second, multiform erythema is
characterized by different forms of cutaneous
lesions, such as exanthema, blisters, and ery-
thema exsudativum, without mucosal involve-
ment. Third, Stevens-Johnson syndrome is
characterized by a rapidly developing blistering
exanthema of purpuric macules and target-like
lesions accompanied by mucosal involvement.
Fourth, toxic epidermal necrolysis is character-
ized by skin detachment of > 30% of body sur-
face area. The diagnosis of each case was
conﬁrmed by occupational panels. The clinical
classiﬁcation of the disease has been described
in detail by Kamijima et al. (2007).
The study was approved by the local insti-
tutional review board, and informed consent
was obtained from all participants.
HLA genotyping. We obtained genomic
DNA from blood by the high-salt method.
HLA alleles HLA-B [UniGene accession no.
Hs.77961 (Unigene 2007)], HLA-DRB1
(UniGene accession no. Hs.654405), HLA-
DQA1 (UniGene accession no. Hs.387679),
and HLA-DQB1 (UniGene accession no.
Hs.409934), were determined by sequence-
based typing protocols (Luo et al. 1999; Pozzi
et al. 1999; Sayer et al. 2004). We then per-
formed bidirectional sequencing. In brief, two
reactions were used to obtain sequences of
both DNA strands of exon 2 for HLA-DQA1,
DQB1, and DRB1, and four reactions were
used to obtain sequences of both DNA strands
of exon 2 and exon 3 for HLA-B. We con-
firmed ambiguity in equivocal combination
results by clone sequencing. We obtained
complete sequencing data for 113 cases and
142 controls; because of insufficient DNA
quality or quantity, DNA samples from
8 cases were excluded from sequencing.
Comparison of amino acid residues. We
translated the amino acid sequences of 1-182
codons (peptide-binding regions) of HLA*B
alleles found in all participants according to
the DNA sequence, and compared the amino
acid residues of HLA molecules that were
positively or nonpositively associated with
hypersensitivity disease. We downloaded
three-dimensional (3D) HLA homology
models from the FIMM website (FIMM
2003); the structural models were generated
by D.R. Flower (Edward Jenner Institute for
Vaccine Research, Compton, Berkshire, UK). 
Statistical analysis. We compared geno-
type frequencies between groups using Fisher’s
exact test. To adjust for multiple comparisons,
we calculated corrected p (pc) values using
Bonferroni’s correction for all observed alleles
(68 for HLA-B, 8 for HLA-DQA1, 28 for
HLA-DQB1, and 78 for HLA-DRB1).
Therefore, the pc value is equal to the p-value
multiplied by a factor of 1,188,096. Because
age and sex were well matched between cases
and controls (Table 1), the odds ratios (ORs)
and their 95% conﬁdence intervals (CIs) were
calculated to estimate the relative risk. To
accommodate zero count, ORs were calcu-
lated with Haldane’s modiﬁcation, which adds
the value of 0.5 to each of the cells with zero
observation. Hierarchical cluster analysis was
used for comparison of amino acid residues
encoded by HLA-B alleles.
Results
Characteristics of cases and controls. The
patients typically showed a rash on the
extremities, face, neck, or trunk with or with-
out fever within 14–40 days after occupational
TCE exposure commenced. The age, sex,
exposure duration, and major clinical manifes-
tations are summarized in Table 1. Exfoliative
Li et al.
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Table 1. Demographic data for the cases and controls.
Cases Controls
Variable ED (n = 77) ME (n = 25) SJS/TEN (n = 11) Total (n = 113) (n = 142)
Age [years (mean ± SD)] 22.9 ± 5.41 22.0 ± 4.18 23.7 ± 6.71 22.8 ± 5.28 23.4 ± 5.24
Male [no. (%)] 32 (41.6) 15 (60.0) 6 (54.5) 53 (46.9) 67 (47.2)
Female [no. (%)] 45 (58.4) 10 (40.0) 5 (45.5) 60 (53.1) 75 (52.8)
TCE exposure duration (months) < 3 < 3 < 3 < 3 > 3
Lymphadenopathy [no. (%)] 56 (72.7) 17 (68.0) 10 (90.9) 83 (73.5) 0 (0.0)
Hepatitis [no. (%)] 64 (83.1) 20 (80.0) 11 (100.0) 95 (84.0) 0 (0.0)
Abbreviations: ED, exfoliative dermatitis; ME, multiform erythema; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal
necrolysis. 
Table 2. Frequencies of HLA-B alleles in cases and controls.
HLA allele Cases (n = 113) Controls (n = 142) OR (95% CI) p-Value pc
B*1301 83 (73.5%) 13 (9.2%) 27.5 (13.5–55.7) 1.76 × 10–27 1.48 × 10–21
B*44 7 (6.2%) 0 (0.0%) 20.1 ( 2.6–157.5) 0.003 > 0.05
B*1301 or B*44 89 (78.8%) 13 (9.2%) 36.8 (17.8–76.1) 1.77 × 10–31 1.49 × 10–25
pc Values and ORs were calculated as described in “Materials and Methods.” dermatitis was the most common clinical
manifestation (68.1%; 77/113). We found six
cases with Stevens-Johnson syndrome and ﬁve
cases with toxic epidermal necrolysis; only one
case was diagnosed with Stevens-Johnson syn-
drome in combination with toxic epidermal
necrolysis. Because Stevens-Johnson syndrome
and toxic epidermal necrolysis are considered
to be the same disease but with varying
degrees of severity, we grouped them together
for further analysis (Kamijima et al. 2007). As
shown in Table 1, there was no signiﬁcant dif-
ference in distributions of sex and age among
these subgroups.
HLA allele frequency. Notably, we found
that the allele HLA-B*1301 was present in
73.5% (83/113) of TCE-induced hypersensi-
tivity dermatitis patients but only in 9.2%
(13/142) of TCE-tolerant workers (OR =
27.5; 95% CI, 13.5–55.7; pc = 1.48 × 10–21).
In addition, the HLA-B*44 alleles, including
B*4402 and B*4403, were present in 6.2%
(7/113) of cases, whereas in TCE-tolerant
workers the alleles were absent (Table 2).
In contrast, we found no significant associa-
tion between HLA-DRB1, HLA-DQA1, or
HLA-DQB1 polymorphisms and the occur-
rence of TCE-induced hypersensitivity der-
matitis (data not shown).
By taking clinical categories into considera-
tion, we found no signiﬁcant difference in fre-
quencies of HLA-B*1301 among the three
subgroups (data not shown).
Characteristics of amino acid residues.
Comparison of 1-182 codons (peptide-binding
regions) of 68 HLA*B alleles in all participants
showed that HLA-B*1301 and HLA-B*44
shared 171 amino acid residues. Hierarchical
cluster analysis also showed that HLA-B*13
and HLA-B*44 have similar amino acid
residues (Figure 1).
Although only three residues were different
between HLA-B*1301 and HLA-B*1302, only
HLA-B*1301 was related to TCE-induced
hypersensitivity dermatitis. The different
residues were I94I95R97 (HLA-B*1301) versus
T94W95T97 (HLA-B*1302). Residue 95 was a
component of peptide-binding pocket
F. Amino acid residues 73, 77, 80, 81, 84, 95,
116, 118, 123, 124, 143, 146, and 147 consti-
tute pocket F of HLA class I molecules (FIMM
2003). One different residue was found
between HLA-B*1301 and HLA-B*1302
(I95 vs. W95). Between HLA-B*1301 and
HLA-B*44, there was a difference in residue
116 (L116 vs. D116). Observations based on
HLA 3D homology models showed that
residue 95, the bottom of the pocket F, formed
a ﬂat structure in W95 (tryptophan) but not in
I95 (isoleucine). In contrast, a similar structure
is present between L116 and D116 (Figure 2). 
Discussion
HLA-B*13 is one of a common allelic group
(phenotype frequency ranges from 10 to 30%)
found in the Chinese population, and the dis-
tribution of HLA-B alleles in the controls of
the present study was similar to that of the
general population in southern China (Feng
et al. 2004; Liang et al. 2005; Shi et al. 2006;
Yang et al. 2006). In addition, the HLA-
B*1301 allele, a member of the HLA-B*13
group in the southern Chinese population, is a
speciﬁc allele in Asians, but is absent in whites
and blacks (Cao et al. 2001; Lin et al. 1995;
Williams et al. 2001). In contrast, HLA-
B*1302 is the predominant allele of the
HLA-B*13 group in whites (Cao et al. 2001;
Williams et al. 2001). The frequencies of
HLA-B*1301 and HLA-B*1302 are variably
distributed in different regions of China. The
frequency of HLA-B*1301 in southern
Chinese is higher than that in northern
Chinese (Feng et al. 2004; Middleton et al.
2004; Shi et al. 2006; Yang et al. 2006). Rapid
economic development, as occurring in China,
could generate a highly mobile work force. As
such, large numbers of new TCE-exposed
workers, combined with genetic features of the
population in southern China, may be a major
factor in the mass outbreaks of TCE-induced
hypersensitivity dermatitis.
The peptides that bind to HLA class I mol-
ecules are restricted in length and often contain
key amino acids (anchor residues) at certain
positions. The side-chains of the peptide
anchor residues interact with the polymorphic
complementary pockets in HLA peptide-
binding grooves and provide the molecular
basis for allele-speciﬁc recognition of antigenic
peptides. HLA polymorphic side-chains delin-
eate the geometry and chemical properties of
six structural pockets (A–F) in the groove that
can accommodate some of the peptide side-
chains. Speciﬁcally, the C-terminal side-chain
of the peptide, which is lodged in pocket F
close to one end of the groove, is important to
the stability of the HLA/peptide complex
(Rammensee et al. 1995). Comparison of
amino acid residues between HLA-B*1301
and HLA-B*1302 showed that only three
residues (I94I95R97 compared with T94W95T97)
were different, and residue 95 is a major com-
ponent of pocket F. By generating recombi-
nant HLA-B molecules and studying the
eluted peptides by mass spectrometry and pool
sequencing, Bade-Doeding et al. (2007) found
that residue 95 causes strong alteration of pep-
tide motifs. According to structure–function
analysis, residue I95 might play a key role in
susceptibility to TCE-induced hypersensitivity
dermatitis.
In addition, HLA-B*44 was present in
6.2% of cases but was not observed in any of
the 142 TCE-tolerant workers. Noticeably,
HLA-B*1301 associated with TCE hypersensitivity
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Figure 1. Hierarchical cluster of 1-182 amino acid
residues of HLA-B alleles were positive and non-
positive associated with trichloroethylene-induced
hypersensitivity dermatitis. Alleles that phenotype
frequencies below 3% in controls were not involved.
HLA-B*1301
HLA-B*1302
HLA-B*44
HLA-B*5101
HLA-B*5201
HLA-B*3802
HLA-B*3901
HLA-B*5502
HLA-B*5401
HLA-B*1502
HLA-B*1501
HLA-B*4601
HLA-B*5801
HLA-B*4001
Figure 2. Comparison of pocket F in tertiary structures among HLA-B*1302 (A), HLA-B*1301 (B), and
HLA-B*44 (C). The corresponding magnified images (D, E, and F, respectively) emphasize the conforma-
tional changes in residue 95 (green) and residue 116 (red).
B AC
E DFHLA-B*1301 and HLA-B*44 shared I94I95R97,
which might play a key role in susceptibility
to TCE-induced hypersensitivity dermatitis
described above. In a previous study that
included 15 white patients, Mondino et al.
(1982) found that HLA-B*44 was associated
with the risk of Stevens-Johnson syndrome
with ocular involvement; therefore, it is pos-
sible that the weak association of HLA-B*44
with hypersensitivity dermatitis in TCE-
exposed workers is not a chance finding.
Certainly, this association should be cau-
tiously considered because of the small num-
ber of patients with the HLA-B*44 allele. 
Recently, strong associations have been
reported between a particular HLA allele and
hypersensitivity dermatitis in patients under
treatment with several drugs. Hypersensitivity
to abacavir, a nucleoside reverse-transcriptase
inhibitor commonly used for anti-AIDS treat-
ment, has been reported to be associated with
an HLA-B allele (HLA-B*5701) and a haplo-
typic Hsp70-Hom variant in the HLA region
(Mallal et al. 2002; Martin et al. 2004).
Chung et al. (2004) reported a strong associa-
tion of a speciﬁc HLA-B allele (HLA-B*1502)
in Chinese patients with carbamazepine-
induced Stevens-Johnson syndrome. In addi-
tion, a significant association was reported
between another HLA-B allele (HLA-B*5801)
and allopurinol-induced cutaneous adverse
reactions both in Chinese patients and in
European patients (Hung et al. 2005; Lonjou
et al. 2006). Interestingly, HLA-B*1301,
HLA-B*1502, and HLA-B*5801, three com-
mon alleles in southern Chinese, shared the
residues I94I95R97, which differed from almost
all other residues present in all participants. In
contrast, HLA-B*1302 and HLA-B*1501 did
not share these residues. Therefore, data from
these studies and from the present study sug-
gest that there is a common molecular basis
for using HLA-B*1301, HLA-B*1502, and
HLA-B*5801 as genetic markers for chemical
hypersensitivity dermatitis in the Chinese
population. 
Taken together, these studies suggest that
HLA-B alleles—alone or together with other
genetic polymorphisms in the HLA region—
might play a pivotal role in determining indi-
vidual susceptibility to hypersensitivity
dermatitis induced by certain chemicals.
Therefore, the mechanism of HLA-B involved
in severe hypersensitivity dermatitis requires
further investigation along these lines.
To our knowledge, this is the ﬁrst report of
the association of the HLA-B*1301 allele with
human disease, and it is the strongest associa-
tion between an HLA marker and a chemical-
related occupational disease described thus far.
Potentially, this association could be used to
develop a highly reliable screening test to pre-
dict high-risk subpopulations to TCE expo-
sure and could be applied for occupational
practice to prevent about 70% of the cases of
this life-threatening disease. In summary,
HLA-B*1301 and HLA-B*44 might play a cru-
cial role in the pathogenesis of TCE-induced
hypersensitivity dermatitis.
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